aDepartment of Nuclear Medical Diagnostic and Therapy, Klinikum Ernst von Bergmann, Potsdam, Germany; bChair and Department of Endocrinology, Jagiellonian University, Medical College, Cracow, Poland
Prof. Dr. Ingo Brink, Department of Nuclear Medical Diagnostic and Therapy, Klinikum Ernst von Bergmann, DE-14467 Potsdam (Germany), E-Mail [email protected], Prof. Alicja Hubalewska-Dydejczyk, Chair and Department of Endocrinology, Jagiellonian University, Medical College, PL-31-008 Cracow (Poland), E-Mail [email protected]
Received: January 14, 2019
Accepted after revision:January 16, 2019
Published online: March 27, 2019
